Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SC401B in severe hypertriglyceridemia
NCT01997268Phase 3Withdrawn
- Sponsor
- Sancilio & Co.
- Primary completion
- Dec 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of SC401B in hypertriglyceridemia, sponsored by Sancilio & Co.. Status: withdrawn.
02
Drugs
SC401B
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT01997268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01997268.